Home › Funds › Two Sigma Investments › CBIO
Two Sigma Investments position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
Latest position (Q2 2026)186.87K sh
Reported value held$3.36M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 54.07K | $222.00K | New |
| Q4 2021 | 308.55K | $282.00K | Add |
| Q1 2022 | 62.73K | $41.00K | Reduce |
| Q3 2025 | 28.32K | $336.70K | New |
| Q4 2025 | 125.22K | $1.49M | Add |
| Q1 2026 | 115.83K | $2.13M | Reduce |
| Q2 2026 | 186.87K | $3.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CBIO
- Fidelity Management & Research (FMR) 4.13M sh · $74.40M · Q2 2026
- Balyasny Asset Management 1.66M sh · $29.93M · Q2 2026
- BlackRock Inc 1.27M sh · $22.89M · Q2 2026
- Millennium Management 403.86K sh · $7.27M · Q2 2026
- Geode Capital Management 384.58K sh · $6.92M · Q2 2026
- Vanguard Group 557.51K sh · $6.61M · Q4 2025
- Point72 Asset Management 300.00K sh · $5.40M · Q2 2026
- Marshall Wace 214.30K sh · $3.86M · Q2 2026
- UBS Group AG 175.18K sh · $3.15M · Q2 2026
- Northern Trust Corp 138.78K sh · $2.50M · Q2 2026
- Charles Schwab Investment Management 50.26K sh · $904.64K · Q2 2026